Literature DB >> 31720847

[Should mitomycin C be used routinely in pterygium surgery?]

K Eisenmann1, F Zeman2, H Helbig1, M-A Gamulescu1, T Barth3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31720847     DOI： 10.1007/s00347-019-01009-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  5 in total

1.  Combined conjunctival rotational autograft with 0.02% mitomycin C in primary pterygium surgery: a long-term follow-up study.

Authors:  Nicole C Tsim; Alvin L Young; Vishal Jhanji; Mary Ho; Lulu L Cheng
Journal:  Br J Ophthalmol       Date:  2015-04-02       Impact factor: 4.638

2.  Evaluation of antimitotic and antiangiogenic effect of preoperative subconjunctival application of mitomycin C in primary pterygium: a randomized trial.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Karina Mie Furuzawa; Roger Chammas; Milton Ruiz Alves
Journal:  Int Ophthalmol       Date:  2019-02-13       Impact factor: 2.031

3.  Effects of mitomycin C on corneal endothelial cell counts in pterygium surgery: role of application location.

Authors:  Ahmad Kheirkhah; Ali Izadi; Mohammad Yaser Kiarudi; Rahman Nazari; Hesam Hashemian; Mahmoud Jabbarvand Behrouz
Journal:  Am J Ophthalmol       Date:  2011-01-13       Impact factor: 5.258

Review 4.  Mitomycin C in pterygium treatment.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Milton Ruiz Alves; Roger Chammas; Paulo Schor
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

5.  [Outcome of pterygium excision after various surgical techniques-is excision with simple conjunctival closure still lege artis?]

Authors:  K Eisenmann; F Zeman; H Helbig; M-A Gamulescu; T Barth
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059
  5 in total
  1 in total

1.  [Pterygium: pathogenesis, diagnosis and treatment].

Authors:  Alexander C Rokohl; Ludwig M Heindl; Claus Cursiefen
Journal:  Ophthalmologe       Date:  2021-03-29       Impact factor: 1.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.